Castle Biosciences Rolls Out AdvanceAD-Tx
Castle Biosciences, Inc. is launching AdvanceAD-Tx, a gene expression profile (GEP) test designed to guide systemic treatment decision-making in patients ages 12 and up with moderate-to-severe atopic dermatitis (AD).